Epilepsy (8 companies)

Companies with an active program in Epilepsy.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
AXSM	Axsome Therapeutics	Neurology Rare	1	Approved	$6.96B	15
ETON	Eton Pharmaceuticals	GI/HepatologyInfectious Disease+3 Rare	1	Approved	$1.63B	17
HRMY	Harmony Biosciences	MetabolicNeurology Rare	2	Approved	$1.94B	17
KZIA	Kazia Therapeutics	NeurologyOncology Rare	1	Phase 2	$82.0M	13
OVID	Ovid Therapeutics	Neurology Rare	1	Phase 2	$557M	4
RAPP	Rapport Therapeutics	Neurology	4	Phase 3	$1.45B	10
QURE	uniQure	HematologyMetabolic+1 Rare	1	Approved	$1.52B	4
XENE	Xenon Pharmaceuticals	Neurology Rare	3	NDA Submitted	$3.79B	9